https://www.selleckchem.com/products/wh-4-023.html
e variants of PTPN14 confer a worse prognosis. Further studies of the specific mutations would be worthwhile.Progressive and metastatic bladder cancer remain difficult to treat. In this review, we critique seven up-regulated and 25 down-regulated microRNAs in order to identify new therapeutic entities and corresponding targets. These microRNAs were selected with respect to their efficacy in bladder cancer-related preclinical in vivo models. MicroRNAs and related targets interfering with chemoresistance, cell-cycle, signaling, apoptosis
Like
Comment
Share
